kentucky semaglutide stomach paralysis class action intestinal lawyer in gi obstruction law firm kentucky semaglutide gastrointestinal obstruction Ozempic Lawsuit for Blindness, and Injury Claims kentucky glp-1 intestinal paralysis – Ozempic Lawsuit: July 2026 Blindness

The scale consists of fourteen items that are rated on a scale of 0 (not at all) to 10 (extremely)

Liver fat reduction proved particularly impressive, with 44% decrease measured by MRI in a subset of participants

This statistic is clinically relevant as obesity increases cardiovascular risk, especially in this relatively young age group

Additionally, using Mounjaro with other similar medications, such as other GLP-1 receptor agonists, is not recommended due to the potential for excessive side effects and no added benefits

The category allows the FDA to keep studying the drug in question, but generally prohibits compounders from selling it to the public until doctors have more proof of its safety and efficacy